← Back

Fosun International Ltd

Fosun International Limited operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates through five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical and health products; and provision of medical and health management services. The Happiness segment operates and invests in tourism and leisure, fashion consumer, and lifestyle industries. The Insurance segment operates and invests in the insurance business. The Asset Management segment engages in the operation and investment of asset management, market investments, and investments in other companies of the Group. The Intelligent Manufacturing segment operates and invests in the intelligent manufacturing business; and produces iron, steel, new functional material, and ore. It is also involved in the capital investment and management, property development, retail, and medical research; tourism business; sale of iron and steel products; retail of jewelry; underwriting of life and non-life insurance; manufacture and trading of dairy products, and wine and beverage; reinsurance services; and provision of banking and financial services, as well as digital and intelligent solutions. The company was founded in 1992 and is based in Central, Hong Kong. Fosun International Limited is a subsidiary of Fosun Holdings Limited.

Price · split & dividend adjusted
News & notes moving 0656.HK
0656.HK

Fosun International Wins Five Awards from Corporate Governance Asia

Fosun International has received five awards from Corporate Governance Asia, including Asia's Best CEO honors for Co-CEOs Chen Qiyu and Xu Xiaoliang. The company also won the Sustainable Asia Award 2026, Best Environmental Responsibility Award, and Best Corporate Communications Award at the 16th Asian Excellence Award ceremony. The recognition highlights Fosun's strong financial performance, corporate governance, and ESG practices amid global economic transformation. Fosun's MSCI ESG rating has been upgraded to AAA, and it has maintained a Hang Seng Sustainability Rating of AA-, while also being included in S&P Global's Sustainability Yearbook 2026. The company continues to advance its sustainability commitments, including a target to peak carbon emissions by 2028 and achieve carbon neutrality by 2050.
PR Newswire·56dRead more ▾
0656.HK

Giantec Semiconductor, Deye Technology, and Yuyantang File for Hong Kong IPO

Giantec Semiconductor, Deye Technology, and Yuyantang have submitted listing applications to the Main Board of the Hong Kong Stock Exchange. Giantec Semiconductor is a high-performance non-volatile memory chip design company, Deye Technology is a global manufacturer of solar and energy storage products, and Yuyantang is a private chain provider of traditional Chinese medicine healthcare services in China. Yonghe Medical expects net profit for the first half of the year to be no less than 70 million yuan, up no less than 150.9 percent year on year, with revenue expected to grow no less than 10.0 percent compared with the same period in 2025. Xipuni expects net profit for the first half to exceed 96 million yuan, up more than 70 percent year on year. Fosun International expects mid-term profit attributable to shareholders of the parent company to be approximately 1.5 billion to 1.8 billion yuan, up about 127 percent to 172 percent year on year.
每日经济新闻·57dRead more ▾